Interstitial 32P-colloid therapy for cancer of the pancreas: Dosimetric considerations
Gespeichert in:
| Veröffentlicht in: | Nuclear medicine communications 1999-05, Vol.20 (5), p.466-466 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 466 |
|---|---|
| container_issue | 5 |
| container_start_page | 466 |
| container_title | Nuclear medicine communications |
| container_volume | 20 |
| creator | McCready, R Atthey, M Nahum, A Flower, M Glees, J Britton, A Masoomi, M Heriot, S Grundy, A |
| description | |
| doi_str_mv | 10.1097/00006231-199905000-00043 |
| format | Article |
| fullrecord | <record><control><sourceid>wolterskluwer_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00006231_199905000_00043</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>00006231-199905000-00043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c943-ac1f210c0c2fa6f81c819f6cd3be90f18c4e63dd659231bd4ae379d86155286d3</originalsourceid><addsrcrecordid>eNp1kM9OAyEQxjloYq2-Ay-wCssuBW-m_mvSRA-NV0IHyKJ0aQDT9O2ltnpzksnMN8k3mfkhhCm5oUTObkkN3jLaUCkl6atqanbsDE0I7VjDOOMX6DLnjzoWjM8m6H0xFpty8cXrgFn71kAMIXqDy2CT3u6xiwmDHsEmHN1hirdVJavzHX6I2W9sSR4wxDF7Uy3F1-4KnTsdsr0-1SlaPT2u5i_N8vV5Mb9fNiDrPRqoaykBAq3T3AkKgkrHwbC1lcRRAZ3lzBjey_rV2nTaspk0gtO-bwU3bIrEcS2kmHOyTm2T3-i0V5SoAxL1i0T9IVE_SKq1O1p3MRwIfIavnU1qsDqUQf1Hkn0DmlBmwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Interstitial 32P-colloid therapy for cancer of the pancreas: Dosimetric considerations</title><source>Journals@Ovid Complete</source><creator>McCready, R ; Atthey, M ; Nahum, A ; Flower, M ; Glees, J ; Britton, A ; Masoomi, M ; Heriot, S ; Grundy, A</creator><creatorcontrib>McCready, R ; Atthey, M ; Nahum, A ; Flower, M ; Glees, J ; Britton, A ; Masoomi, M ; Heriot, S ; Grundy, A</creatorcontrib><identifier>ISSN: 0143-3636</identifier><identifier>DOI: 10.1097/00006231-199905000-00043</identifier><language>eng</language><publisher>Lippincott Williams & Wilkins, Inc</publisher><ispartof>Nuclear medicine communications, 1999-05, Vol.20 (5), p.466-466</ispartof><rights>1999 Lippincott Williams & Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>McCready, R</creatorcontrib><creatorcontrib>Atthey, M</creatorcontrib><creatorcontrib>Nahum, A</creatorcontrib><creatorcontrib>Flower, M</creatorcontrib><creatorcontrib>Glees, J</creatorcontrib><creatorcontrib>Britton, A</creatorcontrib><creatorcontrib>Masoomi, M</creatorcontrib><creatorcontrib>Heriot, S</creatorcontrib><creatorcontrib>Grundy, A</creatorcontrib><title>Interstitial 32P-colloid therapy for cancer of the pancreas: Dosimetric considerations</title><title>Nuclear medicine communications</title><issn>0143-3636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNp1kM9OAyEQxjloYq2-Ay-wCssuBW-m_mvSRA-NV0IHyKJ0aQDT9O2ltnpzksnMN8k3mfkhhCm5oUTObkkN3jLaUCkl6atqanbsDE0I7VjDOOMX6DLnjzoWjM8m6H0xFpty8cXrgFn71kAMIXqDy2CT3u6xiwmDHsEmHN1hirdVJavzHX6I2W9sSR4wxDF7Uy3F1-4KnTsdsr0-1SlaPT2u5i_N8vV5Mb9fNiDrPRqoaykBAq3T3AkKgkrHwbC1lcRRAZ3lzBjey_rV2nTaspk0gtO-bwU3bIrEcS2kmHOyTm2T3-i0V5SoAxL1i0T9IVE_SKq1O1p3MRwIfIavnU1qsDqUQf1Hkn0DmlBmwg</recordid><startdate>199905</startdate><enddate>199905</enddate><creator>McCready, R</creator><creator>Atthey, M</creator><creator>Nahum, A</creator><creator>Flower, M</creator><creator>Glees, J</creator><creator>Britton, A</creator><creator>Masoomi, M</creator><creator>Heriot, S</creator><creator>Grundy, A</creator><general>Lippincott Williams & Wilkins, Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199905</creationdate><title>Interstitial 32P-colloid therapy for cancer of the pancreas: Dosimetric considerations</title><author>McCready, R ; Atthey, M ; Nahum, A ; Flower, M ; Glees, J ; Britton, A ; Masoomi, M ; Heriot, S ; Grundy, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c943-ac1f210c0c2fa6f81c819f6cd3be90f18c4e63dd659231bd4ae379d86155286d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McCready, R</creatorcontrib><creatorcontrib>Atthey, M</creatorcontrib><creatorcontrib>Nahum, A</creatorcontrib><creatorcontrib>Flower, M</creatorcontrib><creatorcontrib>Glees, J</creatorcontrib><creatorcontrib>Britton, A</creatorcontrib><creatorcontrib>Masoomi, M</creatorcontrib><creatorcontrib>Heriot, S</creatorcontrib><creatorcontrib>Grundy, A</creatorcontrib><collection>CrossRef</collection><jtitle>Nuclear medicine communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McCready, R</au><au>Atthey, M</au><au>Nahum, A</au><au>Flower, M</au><au>Glees, J</au><au>Britton, A</au><au>Masoomi, M</au><au>Heriot, S</au><au>Grundy, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interstitial 32P-colloid therapy for cancer of the pancreas: Dosimetric considerations</atitle><jtitle>Nuclear medicine communications</jtitle><date>1999-05</date><risdate>1999</risdate><volume>20</volume><issue>5</issue><spage>466</spage><epage>466</epage><pages>466-466</pages><issn>0143-3636</issn><pub>Lippincott Williams & Wilkins, Inc</pub><doi>10.1097/00006231-199905000-00043</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0143-3636 |
| ispartof | Nuclear medicine communications, 1999-05, Vol.20 (5), p.466-466 |
| issn | 0143-3636 |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_00006231_199905000_00043 |
| source | Journals@Ovid Complete |
| title | Interstitial 32P-colloid therapy for cancer of the pancreas: Dosimetric considerations |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T02%3A45%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wolterskluwer_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interstitial%2032P-colloid%20therapy%20for%20cancer%20of%20the%20pancreas:%20Dosimetric%20considerations&rft.jtitle=Nuclear%20medicine%20communications&rft.au=McCready,%20R&rft.date=1999-05&rft.volume=20&rft.issue=5&rft.spage=466&rft.epage=466&rft.pages=466-466&rft.issn=0143-3636&rft_id=info:doi/10.1097/00006231-199905000-00043&rft_dat=%3Cwolterskluwer_cross%3E00006231-199905000-00043%3C/wolterskluwer_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |